title: [Cytological substantiation of using organosilicon sorbent gentaxan it the treatment of wound infections].
abstract: The main principle in the management of festering wound is the clearance of nidus of infection and so the methods of sorptive therapy are given considerable attention nowadays. We have used a new organosilicon sorbent gentaxan in the treatment of 45 woman recently confined with festering wounds. The obtained findings suggest that the use of gentaxan in treatment of such patients contribute to eliminating factors which hampers wound healing and thus it reduces the term of wound repair by 4-5 days.
authors.forename: A B
authors.initials: AB
authors.lastname: Pryluts'ka
authors.forename: A I
authors.initials: AI
authors.lastname: Pryluts'kyĭ
authors.forename: I A
authors.initials: IA
authors.lastname: Sakharova
mesh_terms: D000005:Abdomen / Q000473:pathology / Q000601:surgery; D000287:Administration, Topical; D000293:Adolescent; D000327:Adsorption; D000328:Adult; D003646:Debridement / Q000379:methods*; D005260:Female; D005836:Genitalia, Female / Q000473:pathology / Q000601:surgery; D006801:Humans; D017646:Organosilicon Compounds / Q000008:administration & dosage*; D049590:Postpartum Period; D013530:Surgical Wound Infection / Q000473:pathology / Q000628:therapy*; D014945:Wound Healing / Q000502:physiology*
chemical_list: D017646:Organosilicon Compounds